FRESENIUS SE & CO KGAA (1FRE.MI) Stock Fundamental Analysis

BIT:1FRE • DE0005785604

50.02 EUR
+0.21 (+0.42%)
Last: Feb 11, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1FRE. 1FRE was compared to 29 industry peers in the Health Care Providers & Services industry. 1FRE has only an average score on both its financial health and profitability. 1FRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • 1FRE had positive earnings in the past year.
  • In the past year 1FRE had a positive cash flow from operations.
  • Of the past 5 years 1FRE 4 years were profitable.
  • In the past 5 years 1FRE always reported a positive cash flow from operatings.
1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCF1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • 1FRE has a Return On Assets of 2.69%. This is comparable to the rest of the industry: 1FRE outperforms 58.62% of its industry peers.
  • With a Return On Equity value of 6.14%, 1FRE perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.90%, 1FRE is in line with its industry, outperforming 51.72% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1FRE is below the industry average of 6.14%.
  • The 3 year average ROIC (2.76%) for 1FRE is below the current ROIC(4.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 4.9%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
1FRE.MI Yearly ROA, ROE, ROIC1FRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.11%, 1FRE belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1FRE has declined.
  • 1FRE has a Operating Margin of 9.76%. This is amongst the best in the industry. 1FRE outperforms 93.10% of its industry peers.
  • In the last couple of years the Operating Margin of 1FRE has declined.
  • 1FRE's Gross Margin of 24.99% is fine compared to the rest of the industry. 1FRE outperforms 62.07% of its industry peers.
  • 1FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
1FRE.MI Yearly Profit, Operating, Gross Margins1FRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • 1FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • 1FRE has about the same amout of shares outstanding than it did 1 year ago.
  • 1FRE has more shares outstanding than it did 5 years ago.
  • 1FRE has a better debt/assets ratio than last year.
1FRE.MI Yearly Shares Outstanding1FRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1FRE.MI Yearly Total Debt VS Total Assets1FRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • 1FRE has an Altman-Z score of 2.09. This is not the best score and indicates that 1FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1FRE has a Altman-Z score of 2.09. This is comparable to the rest of the industry: 1FRE outperforms 58.62% of its industry peers.
  • The Debt to FCF ratio of 1FRE is 11.17, which is on the high side as it means it would take 1FRE, 11.17 years of fcf income to pay off all of its debts.
  • 1FRE has a Debt to FCF ratio of 11.17. This is comparable to the rest of the industry: 1FRE outperforms 44.83% of its industry peers.
  • 1FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating 1FRE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.61, 1FRE belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.09
ROIC/WACC0.87
WACC5.64%
1FRE.MI Yearly LT Debt VS Equity VS FCF1FRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that 1FRE should not have too much problems paying its short term obligations.
  • The Current ratio of 1FRE (1.26) is better than 68.97% of its industry peers.
  • A Quick Ratio of 0.99 indicates that 1FRE may have some problems paying its short term obligations.
  • 1FRE's Quick ratio of 0.99 is fine compared to the rest of the industry. 1FRE outperforms 65.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
1FRE.MI Yearly Current Assets VS Current Liabilites1FRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

  • 1FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.74%, which is quite impressive.
  • Measured over the past years, 1FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
  • 1FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.13%.
  • 1FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.78% on average over the next years. This is quite good.
  • 1FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.95% yearly.
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.78%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1FRE.MI Yearly Revenue VS Estimates1FRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
1FRE.MI Yearly EPS VS Estimates1FRE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.67, the valuation of 1FRE can be described as correct.
  • 75.86% of the companies in the same industry are more expensive than 1FRE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, 1FRE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 13.08, which indicates a correct valuation of 1FRE.
  • 1FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1FRE is cheaper than 72.41% of the companies in the same industry.
  • 1FRE is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.67
Fwd PE 13.08
1FRE.MI Price Earnings VS Forward Price Earnings1FRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 1FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, 1FRE is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 23.5
EV/EBITDA 10.7
1FRE.MI Per share data1FRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • 1FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y12.74%
EPS Next 3Y11.84%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.92%, 1FRE has a reasonable but not impressive dividend return.
  • 1FRE's Dividend Yield is comparable with the industry average which is at 1.80.
  • 1FRE's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1FRE pays out 59.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
1FRE.MI Yearly Income VS Free CF VS Dividend1FRE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
1FRE.MI Dividend Payout.1FRE.MI Dividend Payout, showing the Payout Ratio.1FRE.MI Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

BIT:1FRE (2/11/2026, 7:00:00 PM)

50.02

+0.21 (+0.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.17B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts85.22
Price Target56.15 (12.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)5
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)0.18%
PT rev (1m)1.6%
PT rev (3m)9.65%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-9.16%
EPS NY rev (1m)0.53%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 14.67
Fwd PE 13.08
P/S 1.26
P/FCF 23.5
P/OCF 12.94
P/B 1.51
P/tB 15.21
EV/EBITDA 10.7
EPS(TTM)3.41
EY6.82%
EPS(NY)3.83
Fwd EY7.65%
FCF(TTM)2.13
FCFY4.26%
OCF(TTM)3.87
OCFY7.73%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.06
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 4.9%
ROICexc 5.57%
ROICexgc 12.99%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
ROICexc(3y)2.76%
ROICexc(5y)3.98%
ROICexgc(3y)5.56%
ROICexgc(5y)8.77%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.09
F-Score7
WACC5.64%
ROIC/WACC0.87
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y13.8%
EPS Next 2Y12.74%
EPS Next 3Y11.84%
EPS Next 5Y10.78%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.95%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.72%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / 1FRE.MI FAQ

What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (1FRE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1FRE.MI.


Can you provide the valuation status for FRESENIUS SE & CO KGAA?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (1FRE.MI). This can be considered as Fairly Valued.


How profitable is FRESENIUS SE & CO KGAA (1FRE.MI) stock?

FRESENIUS SE & CO KGAA (1FRE.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for 1FRE stock?

The financial health rating of FRESENIUS SE & CO KGAA (1FRE.MI) is 4 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (1FRE.MI) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (1FRE.MI) is expected to grow by 13.8% in the next year.